This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Merck Sharp + Dohme Corp., Teijin Pharma Limited. Active years: 2020-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2020-2023
Title: The Innovative Contributions of Angela Marie Jablonski
Introduction
Angela Marie Jablonski is a notable inventor based in North Wales, Pennsylvania. She has made significant contributions to the field of cognitive disorders through her innovative research and development of humanized antibodies. With a total of three patents to her name, Jablonski's work is paving the way for new treatments in this critical area of healthcare.
Latest Patents
Jablonski's latest patents focus on a humanized antibody designed for treating or preventing cognitive disorders. The invention provides methods for using and compositions of humanized antibodies that bind tau protein that is phosphorylated at the serine at position 413. This groundbreaking work aims to address the challenges associated with cognitive disorders, offering hope for improved therapeutic options.
Career Highlights
Throughout her career, Angela Marie Jablonski has worked with prominent companies in the pharmaceutical industry, including Teijin Pharma Limited and Merck Sharp & Dohme Corporation. Her experience in these organizations has contributed to her expertise in developing innovative solutions for complex medical issues.
Collaborations
Jablonski has collaborated with esteemed colleagues such as Hiroshi H Eguchi and Takashi Murakami. These partnerships have enhanced her research efforts and expanded the impact of her inventions in the scientific community.
Conclusion
Angela Marie Jablonski's contributions to the field of cognitive disorders through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to inspire advancements in medical treatments, making a significant difference in the lives of those affected by cognitive disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile